hello dear scientist (apologies, it’s been hot today in Perth -...

hello dear scientist (apologies, it’s been hot today in Perth - 39 degrees, so I started the refreshments early). Please talk me through this value that shareholders have been given.

to simplify - can we initially separate the updated strategy with the issue of the new valuable paper (options and piggyback options).

I understand that options have value, and in the case of financial options black and scholes allow us to put a number in it (I always find the implied volatility tricky, but both you and @johndprent seemed to have arrived at 100 in this case, so no arguments here). I’ll accept JDP’s estimates that the value of the options is about $0.10 per share (2 for the original oppie and 8 for the piggybacks).

my question is… how does more paper create this approx 10% increase in value? We have the same drug, same barriers to address, same final market…(@Hunterr - has your target price moved to $33?). Or does @Titans19 have a real beef - this “value” given to shareholders is the other side of the “you’ve just been diluted coin”?